Redmond Asset Management, LLC Medpace Holdings, Inc. Transaction History

Redmond Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$372.0 - $424.34 $16,368 - $18,670	-44 Reduced 1.41%	3,074 $1.27 Million
Q1 2024 May 07, 2024	SELL	$284.87 - $413.31 $9,115 - $13,225	-32 Reduced 1.02%	3,118 $1.26 Million
Q4 2023 Feb 12, 2024	SELL	$227.52 - $312.68 $67,573 - $92,865	-297 Reduced 8.62%	3,150 $965,000
Q3 2022 Nov 10, 2022	SELL	$145.13 - $182.49 $3,047 - $3,832	-21 Reduced 0.61%	3,447 $542,000
Q1 2022 May 03, 2022	BUY	$138.87 - $214.31 $5,277 - $8,143	38 Added 1.11%	3,468 $567,000
Q4 2021 Feb 04, 2022	BUY	$182.74 - $227.9 $4,933 - $6,153	27 Added 0.79%	3,430 $747,000
Q3 2020 Nov 06, 2020	BUY	$92.95 - $130.61 $1,394 - $1,959	15 Added 0.44%	3,403 $380,000
Q1 2020 May 06, 2020	BUY	$61.71 - $101.95 $209,073 - $345,406	3,388 New	3,388 $249,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmond Asset Management, LLC with notifications on news.